Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2006-04-25
2006-04-25
Fredman, Jeffrey (Department: 1637)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
Reexamination Certificate
active
07033801
ABSTRACT:
A method of generating a double stranded (ds) recombinant nucleic acid molecule covalently linked in both strands by contacting two or more ds nucleotide sequences with a topoisomerase under conditions such that both termini of at least one end of a first ds nucleotide sequence are covalently linked by the topoisomerase to both termini of at least one end of a second ds nucleotide sequence is provided. Also provided is a method for generating a ds recombinant nucleic acid molecule covalently linked in one strand, by contacting two or more ds nucleotide sequences with a type IA topoisomerase under conditions such that one strand, but not both strands, of one or both ends of a first ds nucleotide sequence are covalently linked by the topoisomerase. Compositions for performing such methods, and compositions generated from such methods also are provided, as are kits containing components useful for conveniently practicing the methods.
REFERENCES:
patent: 4661450 (1987-04-01), Kempe et al.
patent: 4800159 (1989-01-01), Mullis et al.
patent: 5162209 (1992-11-01), Scheele
patent: 5605802 (1997-02-01), Trono et al.
patent: 5624826 (1997-04-01), Kato et al.
patent: 5746997 (1998-05-01), Reed
patent: 5766891 (1998-06-01), Shuman
patent: 5851808 (1998-12-01), Elledge et al.
patent: 5958681 (1999-09-01), Wetmur et al.
patent: 5981182 (1999-11-01), Jacobs, Jr. et al.
patent: 6013440 (2000-01-01), Lipshutz et al.
patent: 6140086 (2000-10-01), Fox et al.
patent: 6174669 (2001-01-01), Hayashizaki et al.
patent: 6238884 (2001-05-01), Short et al.
patent: 6277632 (2001-08-01), Harney
patent: 6280977 (2001-08-01), Liang et al.
patent: 6291213 (2001-09-01), Rothstein
patent: 6340595 (2002-01-01), Vogels et al.
patent: 6537776 (2003-03-01), Short
patent: 6548277 (2003-04-01), Shuman
patent: 6653106 (2003-11-01), Shuman et al.
patent: 2001/0044137 (2001-11-01), Heyman et al.
patent: 2002/0025561 (2002-02-01), Hodgson
patent: 2002/0028444 (2002-03-01), Harney et al.
patent: 2002/0068290 (2002-06-01), Yarovinsky
patent: 2002/0182731 (2002-12-01), Ji et al.
patent: 0 373 914 (1990-06-01), None
patent: 0 625 572 (1994-11-01), None
patent: 1 018 549 (2000-07-01), None
patent: WO 96/34981 (1976-11-01), None
patent: 85/04898 (1985-11-01), None
patent: WO 94/29443 (1994-12-01), None
patent: WO 96/19497 (1996-06-01), None
patent: WO 97/24455 (1997-07-01), None
patent: WO 97/48716 (1997-12-01), None
patent: WO 98/20122 (1998-05-01), None
patent: WO 98/55502 (1998-12-01), None
patent: WO 98/56943 (1998-12-01), None
patent: WO 00/12687 (2000-03-01), None
patent: WO 00/56878 (2000-09-01), None
patent: WO 01/62892 (2001-08-01), None
patent: WO 01/62943 (2001-08-01), None
patent: WO 02/16594 (2002-02-01), None
Stweart Shuman. Novel approach to molecular cloning and polynucleotide synthesis using Vaccinia DNA topoisomerase. 1994. The Journal of Biological Chemistry 269:32678-32684.
Heyman et al., “Genome-Scale Cloning and Expression of Individual Open Reading Frames Using Topoisomerase I-Mediated Ligation,”Genome Research, pp. 383-392 (1999).
Carninci et al. “High-Efficiency Full-Length cDNA Cloning by Biotinylated CAP Trapper,”Genomics, 37(3):327-36 (1996) Academic Press, Inc.
Carninci et al. “High Efficiency Selection of Full-Length cDNA by Improved Biotinylated Cap Trapper,”DNA Research, 4:61-66 (1997). Universal Academy Press.
Cheng and Shuman, “DNA Strand Transfer Catalyzed by Vaccinia Topoisomerase: Ligation of DNAs Containing a 3′ Mononucleotide Overhang,”Nucleic Acids Res., 28(9):1893-1898. (2000). Oxford University Press.
Cheng and Shuman, “Recombinogenic Flap Ligation Pathway for Intrinsic Repair of Topoisomerase IB-Induced Double-Strand Breaks,”Mol. Cell. Biol.20(21):8059-8068 (2000) American Society for Microbiology.
Cheng and Shuman, “Site-Specific DNA Transesterification by Vaccinia Topoisomerase: Role of Specific Phosphates and Nucleosides,”Biochemistry38(50):16599-16612 (1999) American Chemical Society.
Cheng and Shuman, “A Catalytic Domain of Eukaryotic DNA Topoisomerase I,”J. Biol. Chem.273(19):11589-11595 (1998) The American Society for Biochemistry and Molecular Biology, Inc.
Cheng et al., “Conservation of Structure and Mechanism Between Eukaryotic Topoisomerase I and Site-Specific Recombinases,”Cell.92(6):841-850 (1998) Cell Press.
Cheng et al., “Mutational Analysis of 39 Residues of Vaccinia DNA Topoisomerase Identifies Lys-220, Arg-223, and Asn-228 as Important for Covalent Catalysis,”J. Biol. Chem.272(13):8263-8269 (1997) The American society for Biochemistry and Molecular Biology, Inc.
DiGate and Marians, “Molecular Cloning and DNA Sequence Analysis ofEscherichia colitopB, the Gene Encoding Topoisomerase III,”J. Biol. Chem.264(30):17924-17930 (1989). The American society for Biochemistry and Molecular Biology, Inc.
Edery et al., “An Efficient Strategy to Isolate Full-Length cDNAs Based on an mRNA Cap Retention Procedure (CAPture),”Mol. Cell. Biol., 15(6):3363-3371 (1995). American Society for Microbiology.
Ericsson et al., “Characterization of ts16, a Temperature-Sensitive Mutant of Vaccinia Virus,”J. Virol., 69(11):7072-7086 (1995) American Society for Microbiology.
Gross and Shuman, “Vaccinia Virions Lacking the RNA Helicase Nucleoside Triphosphate Phosphohydrolase II are Defective in Early Transcription,”J. Virol.70(12):8549-8557 (1996) American Society for Microbiology.
Haghighat and Sonenberg. “eIF4G Dramatically Enhances the Binding of eIF4E to the mRNA 5′-Cap Structure,”J. Biol. Chem., 272(35):21677-21680 (1997). The American society for Biochemistry and Molecular Biology, Inc.
Haghighat et al., “The eIF4G-eIF4E Complex is the Target for Direct Cleavage by the Rhinovirus 2A Proteinase,”J. Virol.70:8444-8450 (1996). American Society for Microbiology.
Henningfeld and Hecht, “A Model for Topoisomerase I-Mediated Insertions and Deletions with Duplex DNA Substrates Containing Branches, Nicks, and Gaps,”Biochemistry34(18):6120-6129. (1995) American Chemical Society.
Invitrogen Corporation.Invitrogen Catalog, Carlsbad, California, pp. 18, 29, 43, 44, 49-52 (1998).
Janknecht et al., “Rapid and Efficient Purification of Native Histidine-Tagged Protein Expressed by Recombinant Vaccinia Virus,”Proc. Natl. Acad. Sci., U S A88:8972-8976 (1991) National Academic of Sciences.
Kane and Shuman, “Vaccinia Virus Morphogenesis is Blocked by a Temperature-Sensitive Mutation in the I7 Gene that Encodes a Virion Component,”J. Virol.67(5):2689-2698 (1993) American Society for Microbiology.
Kato et al., “Construction of a Human Full-Length cDNA Bank,”Gene.150: 243-250 (1994) Elsevier Science.
Klemm et al., “Peptide Inhibitors of DNA Cleavage by Tyrosine Recombinases and Topoisomerases,”J. Mol. Biol.299(5):1203-1216. (2000) Academic Press, Inc.
Klemperer et al., “Identification and Characterization of the orf Virus Type I Topoisomerase,”Virology206:203-215 (1995) Academic Press, Inc.
Krogh and Shuman, “Vaccinia Topoisomerase Mutants Illuminate Conformational Changes During Closure of the Protein Clamp and Assembly of a Functional Active Site,”J. Biol. Chem.Jul. 5, 2001 [Manuscript] The American Society for Biochemistry and Molecular Biology, Inc.
Krogh and Shuman, “Catalytic Mechanism of DNA Topoisomerase IB,”Mol. Cell.,5(6):1035-1041 (2000) Cell Press.
Krogh and Shuman, “DNA Strand Transfer Catalyzed by Vaccinia Topoisomerase: Peroxidolysis and Hydroxylaminolysis of the Covalent Protein-DNA Intermediate,”Biochemistry39(21):6422-6432. (2000) American Chemical Society.
Krogh et al., “Effect of 2′-5′ Phosphodiesters on DNA Transesterification by Vaccinia Topoisomerase,”J. Biol. Chem.276(24):20907-20912. (2001) The American Society for Biochemistry and Molecular Biology, Inc.
Krogh et al., “Melanoplus Sanguinipes Entomopoxvirus DNA
Bennett Robert P.
Carrino John
Chesnut Jonathan D.
Fan James
Gleeson Martin A.
DLA Piper Rudnick Gray Cary US LLP
Fredman Jeffrey
Invitrogen Corporation
LandOfFree
Compositions and methods for rapidly generating recombinant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for rapidly generating recombinant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for rapidly generating recombinant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3579854